Maurizio Cecconi is the Deputy Scientific Director for clinical research at Humanitas Research Hospital, where he is also the Head of the Anaesthesia and Intensive Care Department. He is full professor of Anaesthesia and Intensive Care at Humanitas University and the Director of the Residency School of Anaesthesia at the same university.
He completed his studies and specialization in Italy (University of Udine), Spain (Universidad Autonoma de Madrid), the UK (doctoral degree at St George’s University of London), and the USA (research program GCSRT at Harvard Medical School). He worked for 14 years as an NHS Consultant at St George’s Hospital, London, UK, where he chaired one of Europe’s largest Critical Care Departments. He is the immediate Past President of the European Society of Intensive Care Medicine, leading through the most challenging times of its history during the COVID-19 pandemic. He designed and directed the EU-funded C19_SPACE to 20000 healthcare workers.
Under his Leadership, ESICM established its reputation within European Institutions and was awarded the Gastein Health Forum European Health Leadership Award in 2021. In 2018, he was awarded the Silver Griffin by his Alma Mater, the University of Udine. In 2020, he was mentioned by JAMA as one of the most influential doctors of the pandemic, and was nominated Knight of the Order of Merit of the Italian Republic.
Cecconi conducts extensive research programs in anesthesia and intensive care medicine. His work in anesthesia and perioperative medicine includes optimizing perioperative care, developing fluid administration methods, and advancing hemodynamic monitoring to reduce postoperative complications. His intensive care studies have improved fluid administration for cardiovascular shock and sepsis. Additionally, he’s researched venous return physiology, fluid challenges, acute respiratory failure, ARDS, and surgical outcomes epidemiology. Recently, he has explored machine learning and artificial intelligence applications in the above fields.
Cecconi has led notable observational studies and randomized controlled trials. His research is published in leading journals, such as the Lancet, New England Journal of Medicine, JAMA, and Intensive Care Medicine. He is invited regularly as a speaker at leading international conferences and Institutions.
His work is highly cited; as of July 2024, he has an h-index of 88 according to Google Scholar.